115 related articles for article (PubMed ID: 30587910)
21. Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].
Onco Targets Ther; 2017; 10():1709. PubMed ID: 28356758
[TBL] [Abstract][Full Text] [Related]
22. Erratum: Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle [Corrigendum].
Int J Nanomedicine; 2018; 13():4207-4208. PubMed ID: 30050298
[TBL] [Abstract][Full Text] [Related]
23. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():1365. PubMed ID: 26229429
[TBL] [Abstract][Full Text] [Related]
24. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():453. PubMed ID: 25834381
[TBL] [Abstract][Full Text] [Related]
25. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.
Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P
Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284
[TBL] [Abstract][Full Text] [Related]
26. Erratum: An intervention designed to improve sensory impairments in the elderly and indoor lighting in their homes: an exploratory randomized controlled trial [Corrigendum].
J Multidiscip Healthc; 2015; 8():321. PubMed ID: 26185451
[TBL] [Abstract][Full Text] [Related]
27. Erratum: Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain [Corrigendum].
J Pain Res; 2018; 11():1163. PubMed ID: 29950887
[TBL] [Abstract][Full Text] [Related]
28. Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].
Neuropsychiatr Dis Treat; 2017; 13():2219. PubMed ID: 28860779
[TBL] [Abstract][Full Text] [Related]
29. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Bonini S; Lambiase A; Rama P; Sinigaglia F; Allegretti M; Chao W; Mantelli F;
Ophthalmology; 2018 Sep; 125(9):1332-1343. PubMed ID: 29653858
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.
Stevenson D; Tauber J; Reis BL
Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092
[TBL] [Abstract][Full Text] [Related]
31. Erratum: Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review [corrigendum].
Int Med Case Rep J; 2019; 12():21. PubMed ID: 30787640
[TBL] [Abstract][Full Text] [Related]
32. Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237).
Kanda M; Nowak V
Ophthalmology; 2020 Jul; 127(7):e43. PubMed ID: 32564819
[No Abstract] [Full Text] [Related]
33. Erratum: Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum].
Clin Interv Aging; 2017; 12():1205. PubMed ID: 28814846
[TBL] [Abstract][Full Text] [Related]
34. Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease.
Clark D; Tauber J; Sheppard J; Brady TC
Am J Ophthalmol; 2021 Jun; 226():22-31. PubMed ID: 33529588
[TBL] [Abstract][Full Text] [Related]
35. Erratum: Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum].
Clin Interv Aging; 2016; 11():775. PubMed ID: 27358559
[TBL] [Abstract][Full Text] [Related]
36. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
[TBL] [Abstract][Full Text] [Related]
37. Erratum: A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum.
Clin Pharmacol; 2018; 10():71. PubMed ID: 29928148
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Delayed manifestation of bilateral scleral thinning after I-BRITE(®) procedure and review of literature for cosmetic eye-whitening procedures [Corrigendum].
Clin Ophthalmol; 2016; 10():187. PubMed ID: 26869752
[TBL] [Abstract][Full Text] [Related]
39. Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).
Holland EJ; Luchs J; Karpecki PM; Nichols KK; Jackson MA; Sall K; Tauber J; Roy M; Raychaudhuri A; Shojaei A
Ophthalmology; 2017 Jan; 124(1):53-60. PubMed ID: 28079022
[TBL] [Abstract][Full Text] [Related]
40. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
